
|
Cost-Effectiveness
of Syringe Exchange as an HIV Prevention Strategy [Laufer FN
JAIDS 2001:28:273] The author analyzed cost-effectiveness
of the New York State approved syringe exchange programs to determine
cost-effectiveness based on data provided by seven such programs.
Background data of interest indicated that injection drug users
reused syringes an average of over seven times [STAT Med
1994;13:2179], and further studies showed that syringe exchange
programs can reduce average circulation time from 23.5 days to less
than three days [AIDS 1994;8:567]. Data considered in the
cost analysis was HIV seroprevalence in IDUs of 0.4, a syringe exchange
attendance rate of 0.5, and an HIV reduction of 3.35/100 person-years
at risk. Based on these assumptions, it was calculated that 87 HIV
infections would be averted in the seven programs with a total cost
of $1.8 million for a cost-effectiveness ratio of $20,947 per HIV
infection averted. The authors conclude that syringe exchange is
highly cost-effective for reducing HIV transmission.
Comment:
This
study provides convincing data on the value of syringe exchange
as an effective method to reduce HIV transmission. Like needle exchange,
the issue is embroiled in politics. Nevertheless, the potential
value of these programs was extended in New York State by the "Expanded
Syringe Access Demonstration Program," which permits sale or
furnishing of up to ten needles and syringes without prescription
to persons over 18 years of age by licensed pharmacies and health
care facilities. The program began January 1, 2001 and is expected
to reach a larger portion than those served by syringe exchange
programs.
posted
11/19/2001

|

|